Free Trial
NASDAQ:TBIO

Telesis Bio (TBIO) Stock Price, News & Analysis

Telesis Bio logo
$0.02 -0.28 (-91.90%)
As of 07/14/2025 02:53 PM Eastern

About Telesis Bio Stock (NASDAQ:TBIO)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.01
$0.30
52-Week Range
$0.01
$6.17
Volume
663 shs
Average Volume
6,682 shs
Market Capitalization
$43.79 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter.

TBIO Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Telesis Bio Announces Departure of Chief Legal Officer
See More Headlines

TBIO Stock Analysis - Frequently Asked Questions

Telesis Bio's stock was trading at $0.40 at the start of the year. Since then, TBIO shares have decreased by 93.9% and is now trading at $0.0243.

Telesis Bio, Inc. (NASDAQ:TBIO) announced its earnings results on Monday, November, 8th. The company reported ($6.12) EPS for the quarter, missing the consensus estimate of ($5.04) by $1.08. The company earned $2.79 million during the quarter, compared to the consensus estimate of $2.93 million.

Shares of Telesis Bio reverse split on the morning of Thursday, May 9th 2024.The 1-18 reverse split was announced on Thursday, May 9th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 9th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Telesis Bio (TBIO) raised $100 million in an initial public offering on Thursday, June 28th 2018. The company issued 7,700,000 shares at $12.00-$14.00 per share. Citigroup, Leerink Partners and Evercore ISI served as the underwriters for the IPO.

Shares of TBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Telesis Bio investors own include Ford Motor (F), Pfizer (PFE), PayPal (PYPL), SoFi Technologies (SOFI), Plug Power (PLUG) and XPeng (XPEV).

Company Calendar

Last Earnings
11/08/2021
Today
7/14/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:TBIO
Previous Symbol
NASDAQ:DNAY
CIK
1850079
Fax
N/A
Employees
200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($28.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.72 million
Net Margins
-336.59%
Pretax Margin
-334.81%
Return on Equity
N/A
Return on Assets
-61.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.23
Quick Ratio
1.06

Sales & Book Value

Annual Sales
$225.09 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.14 per share
Price / Book
0.17

Miscellaneous

Outstanding Shares
1,802,000
Free Float
1,360,000
Market Cap
$43.79 thousand
Optionable
Optionable
Beta
0.96
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:TBIO) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners